| SNCG |
Homo sapiens |
|
SNCG is differentially expressed in 70 experiments [95 up/92 dn]: 38 organism parts: spinal cord [2 up/0 dn], white blood cells [0 up/1 dn], ...; 23 disease states: normal [7 up/3 dn], glioblastoma [0 up/2 dn], ...; 16 cell types, 21 cell lines, 16 compound treatments and 18 other conditions. |
| BCSG1, PERSYN, PRSN, hCG_23263, SNCG |
|
SYUG_RAT (Rattus norvegicus)
Sncg (Mus musculus)
(Compare orthologs)
|
|
|
| Gamma-synuclein, Synuclein |
|
|
| adult locomotory behavior, axon, cytoplasm, neuronal cell body, protein binding |
|
|
|
O76070
Q6FHG5
|
|
|
|
ENSG00000173267
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Normal
|
Disease state |
|
|
None
|
Compound treatment |
|
|
Glioblastoma
|
Disease state |
|
|
Macaca mulatta
|
Organism |
|
|
Pan troglodytes
|
Organism |
|
|
ERbeta transfected
|
Genotype |
|
|
FLAP
|
Compound treatment |
|
|
MK886
|
Compound treatment |
|
|
Control
|
Compound treatment |
|
|
PC3
|
Cell line |
|
|
Cystic change
|
Histology |
|
|
Homo sapiens
|
Organism |
|
|
Spinal cord
|
Organism part |
|
|
HNRPA2B
|
Compound treatment |
|
|
White blood cells
|
Organism part |
|
|
Caudate nucleus
|
Organism part |
|
|
Frontal cortex, superior motor...
|
Organism part |
|
|
Grade IV
|
Tumor grading |
|
|
Epilepsy
|
Disease state |
|
|
Cerebellum
|
Organism part |
|
|
Tumor
|
Organism part |
|
|
T47D
|
Cell line |
|
|
Frontal cortex, primary motor ...
|
Organism part |
|
|
Pretreatment primary sample
|
Clinical info |
|
|
SW480
|
Cell line |
|
|
SW620
|
Cell line |
|
|
MCF7
|
Cell line |
|
|
Lymphatic endothelial cell
|
Cell type |
|
|
HPL1
|
Cell line |
|
|
HaCaT
|
Cell line |
|
|
Enzo Labeling
|
Protocol type |
|
|
Thalamus
|
Organism part |
|
|
Glucocorticoid resistant
|
Phenotype |
|
|
Fetal lung
|
Organism part |
|
|
Uninfected
|
Infection |
|
|
Lung
|
Organism part |
|
|
Bacterial endotoxin
|
Compound treatment |
|
|
Organism_part
|
Material type |
|
|
Cell
|
Material type |
|
|
Glucocorticoid sensitive
|
Phenotype |
|
|
ERalpha transfected
|
Genotype |
|
|
Affymetrix Labeling
|
Protocol type |
|
|
G3
|
Tumor grading |
|
|
MDA468
|
Cell line |
|
|
Cancer16
|
Replicate |
|
|
Spermatid
|
Cell type |
|
|
Methotrexate
|
Compound treatment |
|
|
Vascular smooth muscle cell
|
Cell type |
|
|
MCF10A
|
Cell line |
|
|
Superficial transitional cell ...
|
Disease state |
|
|
BT474
|
Cell line |
|
|
Chondrocyte
|
Cell type |
|
|
Ciliary ganglion
|
Organism part |
|
|
Cingulate cortex
|
Organism part |
|
|
TaN0M0
|
Disease staging |
|
|
SsMCF7
|
Cell line |
|
|
Dorsal root ganglion
|
Organism part |
|
|
Control
|
RNAi |
|
|
SIM2s
|
RNAi |
|
|
MDA-MB-231
|
Cell line |
|
|
T3aNxMx
|
Disease staging |
|
|
Bone marrow
|
Organism part |
|
|
Prefrontal cortex
|
Organism part |
|
|
Temporal lobe
|
Organism part |
|
|
Liver
|
Organism part |
|
|
Psoriatic lesional biopsy
|
Clinical info |
|
|
Uninvolved biopsy
|
Clinical info |
|
|
Testis
|
Organism part |
|
|
T4aN0M0
|
Disease staging |
|
|
Dimethyl sulfoxide
|
Compound treatment |
|
|
Trichostatin A
|
Compound treatment |
|
|
Monocyte
|
Cell type |
|
|
T4aN2Mx
|
Disease staging |
|
|
Acute malaria, natural infecti...
|
Disease state |
|
|
Breast carcinoma
|
Disease state |
|
|
MCF-7
|
Cell line |
|
|
Beta cell islets
|
Organism part |
|
|
T47-D
|
Cell line |
|
|
T1bN0M0
|
Disease staging |
|
|
Not applicable
|
Histology |
|
|
Pancreas
|
Organism part |
|
|
HMEC184
|
Cell line |
|
|
Johnsen score count 2: Sertoli...
|
Histology |
|
|
Smooth muscle
|
Organism part |
|
|
NCI-N87
|
Cell line |
|
|
17beta-estradiol
|
Compound treatment |
|
|
5-aza-2'-deoxycytidine
|
Compound treatment |
|
|
Grade III
|
Tumor grading |
|
|
Papillary thyroid carcinoma
|
Disease state |
|
|
Brain
|
Organism part |
|
|
Fetal brain
|
Organism part |
|
|
Parietal lobe
|
Organism part |
|
|
Benign prostatic hyperplasia
|
Disease state |
|
|
Prostate carcinoma
|
Disease state |
|
|
Primary cells
|
Cell line |
|
|
Skeletal muscle
|
Organism part |
|
|
KSHV infection
|
Disease state |
|
|
N/a
|
Test result |
|
|
Rapamycin
|
Compound treatment |
|
|
Jurkat
|
Cell line |
|
|
CodeLink Labeling
|
Protocol type |
|
|
Seminiferous tubule
|
Organism part |
|
|
Malignant melanoma
|
Disease state |
|
|
Cartilage
|
Organism part |
|
|
HL-60
|
Cell line |
|
|
CD3+ CD4+ CD8- CD45RA+ CD62L+
|
Phenotype |
|
|
Naive T cell
|
Cell type |
|
|
Head and neck squamous cell ca...
|
Disease state |
|
|
T2N0M0
|
Disease staging |
|
|
Amygdala
|
Organism part |
|
|
GLI60
|
Cell line |
|
|
Baseline uninfected
|
Disease state |
|
|
Whole brain
|
Organism part |
|
|
Plasma cell
|
Cell type |
|
|
B lymphocyte
|
Cell type |
|
|
Bladder carcinoma
|
Disease state |
|
|
Subthalamic nucleus
|
Organism part |
|
|
Multipotent adult progenitor c...
|
Cell type |
|
|
5-aza-2'-deoxycytidine + trich...
|
Compound treatment |
|
|
Primary lymphatic endothelial ...
|
Cell type |
|
|
Whole blood
|
Organism part |
|
|
White blood cell
|
Cell type |
|
|
Platelet
|
Cell type |
|
|
KSHV latent infection
|
Disease state |
|
|
Vanadium pentoxide
|
Compound treatment |
|
|
Non-ischemic cardiomyopathy
|
Disease state |
|
|
Spermatocyte
|
Cell type |
|
|
CD34+
|
Cell type |
|
|
T3bN1M0
|
Disease staging |
|
|
Endometrioid carcinoma
|
Disease state |
|
|
TIVE
|
Cell line |
|
|
Adult
|
Developmental stage |
|
|
Infant
|
Developmental stage |
|
|
Thyroid
|
Organism part |
|
|
Fetal liver
|
Organism part |
|
|
Trigeminal ganglion
|
Organism part |
|
|
Sporadic basal-like breast can...
|
Disease state |
|
|
Hydroxyurea
|
Compound treatment |
|
|
Duodenum
|
Organism part |
|
|
Rheumatoid arthritis
|
Disease state |
|
|
Primary bone marrow CD34+ stem...
|
Cell type |
|
|
Vasectomized
|
Clinical history |
|
|
DMSO
|
Vehicle |
|
|
Granulocyte macrophage-colony ...
|
Compound treatment |
|
|
T4aN2M1
|
Disease staging |
|
|
Cyclosporin A, mycophenolate m...
|
Clinical treatment |
|
|
Sirolimus, mycophenolate mofet...
|
Clinical treatment |
|
|
Stage I
|
Disease staging |
|
|
Stage II
|
Disease staging |
|
|
T3bN0M0
|
Disease staging |
|
|
Occipital lobe
|
Organism part |
|
|
Term
|
Developmental stage |
|
|
Midgestation
|
Developmental stage |
|
|
Thymus
|
Organism part |
|
|
Stromal cell
|
Cell type |
|
|
0 cm away from the tumor bound...
|
Observation |
|
|
Kaposi's sarcoma
|
Disease state |
|
|
Wild_type
|
Genotype |
|
|
Carcinoma in situ lesion
|
Disease state |
|
|
Adrenal gland
|
Organism part |
|
|
Teratozoospermia
|
Disease state |
|
|
Normospermic
|
Disease state |
|
|
|
|
|
Processing time: 0.107 secs.